⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GILD News
Gilead Sciences Inc
EQT Life Sciences to exit minority stake in Tubulis via sale to Gilead Sciences for up to USD 5.0 billion
prnewswire.com
GILD
Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline
businesswire.com
GILD
Next Generation Drug Conjugates (NDCs) Market worth $42.55 billion by 2035 | MarketsandMarkets™
prnewswire.com
ALNY
GILD
IONQ
ABBV
ARWR
Centri Announces Panel Topics and Featured Programming for Second Annual Capital Conference at Nasdaq on April 14
accessnewswire.com
NDAQ
DFIN
PTGX
STRL
TNDM
AXSM
CSTL
CYTK
GILD
INSM
KODK
NBIX
OCGN
REGN
SRPT
VRTX
XBIT
AMZN
GOOGL
MSFT
NVDA
IBM
ORGN
BWEN
CCJ
EXC
NEE
SO
UTL
XOM
BALY
OXY
PBF
CHRD
AX
BAC
MAXN
PHIO
KZR
SMX
DUOT
COIN
EHTH
Global Virus Network Meeting Advances a Science-Driven Agenda for Pandemic Preparedness
globenewswire.com
PFE
MRK
JNJ
BMY
GILD
Gilead Extends Tender Offer to Acquire Arcellx
businesswire.com
GILD
Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides
accessnewswire.com
NNVC
GILD
SIGA
EBS
Cell Therapy Market Size to Surpass USD 17.15 Billion by 2032, Driven by Chronic Disease Treatment and CAR-T Therapy Growth, Says New MMR Analysis
prnewswire.com
GILD
JNJ
BMY
REGN
VERI
RXRX
MAGN
ALLO
CORRECTION FROM SOURCE: CIO 100 Awards & Conference Announces 2026 CIO 100 Honorees, Recognizing Enterprise-Scale Technology Leadership
accessnewswire.com
HPE
IBM
AVNT
BAC
BSM
CTSH
DELL
DOX
DG
DD
ECL
FDX
FICO
INTC
JNJ
MA
OII
PEP
QCOM
RS
S
TMO
TRV
UNM
UPS
VZ
WCC
ABBV
ACAD
AES
ALB
ALLY
AMAT
AZN
T
AVPT
CBRE
CI
COST
DE
EL
GE
GILD
JLL
JPM
KHC
LMT
MS
NWSA
PENN
PFE
REGN
ROK
SAN
SM
SIRI
TMUS
TRIP
WEN
CVS
AMZN
GOOGL
MSFT
ORCL
CRM
ADBE
NFLX
NVDA
AMD
CSCO
HPQ
ACN
ADP
AMGN
BA
CAT
CMCSA
COP
DIS
DOW
EOG
HON
KO
LIN
LRCX
MDT
META
MRK
MU
NEE
RTX
SBUX
SMCI
SNPS
SO
SPG
TCOM
TGT
TXN
UNH
VRTX
WFC
XOM
ZTS
NorthSea Therapeutics Bolsters Board, as Orziloben Moves into Late-stage Development
globenewswire.com
MIRM
ALGN
JNJ
GILD